Jian Zhou

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma.
  2025 L1 66/100

1 assessed by us (0 reproduced) · 469 not yet assessed — every PubMed paper on record, linked below.

• A multi‐centre, prospective trial of a methylation‐based liquid biopsy for early detection of liver cancer in high‐risk populations ↗

  Clinical and Translational Medicine · 2026 · PMID 42145083
  not yet assessed
• Tumor‐Infiltrating mregDCs Restrain Anti‐Tumor Immunity in Early Relapse HCC ↗

  Advanced Science · 2026 · PMID 42133204
  not yet assessed
• Glucose metabolic reprogramming as a driver of immunosuppression in the tumour microenvironment ↗

  Clinical and Translational Medicine · 2026 · PMID 42163583
  not yet assessed
• Figure S2 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Figure S3 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Figure S8 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Figure S4 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Table S4 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Figure S1 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Table S2 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Table S3 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Table S1 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Figure S9 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Figure S10 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Figure S7 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Data from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Figure S5 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Figure S6 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Table S5 from Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  2026
  not yet assessed
• Spatiotemporal multiomics uncover tumor ecosystem dynamics during metastatic colonization ↗

  Science · 2026 · PMID 42531396
  not yet assessed
• Norepinephrine promotes tumour cell aggressiveness and NK cell ferroptosis via ADRB2 in intrahepatic cholangiocarcinoma with perineural invasion ↗

  Gut · 2026 · PMID 42009561
  not yet assessed
• Arachidonic Acid Metabolism in PMN-MDSCs Suppresses Antitumor Capacity of T Cells in <i>KRAS</i> -Mutant Cholangiocarcinoma ↗

  Cancer Discovery · 2026 · PMID 41949259
  not yet assessed
• Tumor-Infiltrating Platelets Recruit Neutrophils to Promote Tumor Growth through the 5-HIAA–GPR35–ERK1/2 Axis in Hepatocellular Carcinoma ↗

  Cancer Immunology Research · 2026 · PMID 41962042
  not yet assessed
• Patient-derived organotypic tumor spheroids as a functional platform for predicting immunotherapeutic responses and guiding precision treatment for hepatocellular carcinoma ↗

  Journal for ImmunoTherapy of Cancer · 2026 · PMID 42082269
  not yet assessed
• Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma ↗

  Cell Discovery · 2025 · PMID 39870619
  not yet assessed
• Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma ↗

  Nature Communications · 2025 · PMID 40695827
  not yet assessed
• Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study ↗

  The Lancet Oncology · 2025 · PMID 40889502
  not yet assessed
• Loss of SGK1 supports metastatic colonization in hepatocellular carcinoma by promoting resistance to T cell-mediated immunity ↗

  Journal of Hepatology · 2025 · PMID 39892819
  not yet assessed
• Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells ↗

  Signal Transduction and Targeted Therapy · 2025 · PMID 39837814
  not yet assessed
• Targeting HMGB2 acts as dual immunomodulator by bolstering CD8 ⁺ T cell function and inhibiting tumor growth in hepatocellular carcinoma ↗

  Science Advances · 2025 · PMID 40315321
  not yet assessed
• Apelin-13 attenuates optic nerve damage in glaucomatous mice by regulating glucose metabolism ↗

  Journal of Translational Medicine · 2025 · PMID 39966959
  not yet assessed
• First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study ↗

  Signal Transduction and Targeted Therapy · 2025 · PMID 40835595
  not yet assessed
• Contemporaneous and temporal symptom drivers during breast cancer chemotherapy: A prospective repeated-measures cohort study ↗

  European Journal of Oncology Nursing · 2025 · PMID 41004877
  not yet assessed
• Influenza A Virus and Mycoplasma pneumoniae Coinfection Mediates Immune Dysregulation and Exacerbates Disease Severity ↗

  International Journal of Molecular Sciences · 2025 · PMID 41226526
  not yet assessed
• Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation ↗

  Nature Communications · 2025 · PMID 41249197
  not yet assessed
• Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial ↗

  ˜The œLancet. Gastroenterology & hepatology · 2025 · PMID 41319673
  not yet assessed
• Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma

  Nature Communications · 2025 · PMID 41387425
  L1 66/100
• Targeting MORF4L1-mediated DNA repair potentiates RT-induced antitumor immunity via cGAS-STING activation in hepatocellular carcinoma ↗

  Cellular and Molecular Immunology · 2025 · PMID 41188483
  not yet assessed
• CD177 ⁺ neutrophils drive extracellular matrix remodelling and HGF-alpha release in ALPPS-induced liver regeneration ↗

  Gut · 2025 · PMID 41390175
  not yet assessed
• Survival outcomes between haploidentical stem cell transplantation and chemotherapy for blastic plasmacytoid dendritic cell neoplasm ↗

  Bone Marrow Transplantation · 2025 · PMID 39939432
  not yet assessed
• An mRNA Vaccine Targeting the C-Terminal Region of P1 Protein Induces an Immune Response and Protects Against Mycoplasma pneumoniae ↗

  International Journal of Molecular Sciences · 2025 · PMID 40650312
  not yet assessed
• Liver regeneration–associated hepatocellular YAP1 activation prevents colorectal cancer liver metastasis through glutamine competition ↗

  Science Advances · 2025 · PMID 40845109
  not yet assessed
• An unsupervised learning method based on U-Net + + for low-light image enhancement ↗

  Signal Image and Video Processing · 2025
  not yet assessed
• Guideline of precisional testing in intrahepatic cholangiocarcinoma: an international expert consensus ↗

  Clinical Cancer Bulletin · 2025
  not yet assessed
• Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study ↗

  Journal of Hepatocellular Carcinoma · 2025 · PMID 40420928
  not yet assessed
• Postoperative circulating tumor cells predict the benefits of tyrosine kinase inhibitor for hepatocellular carcinoma after transplantation ↗

  Hepatology Research · 2025 · PMID 40317587
  not yet assessed
• Poliovirus shedding after sequential immunization of Sabin-strain inactivated polio vaccines and oral attenuated polio vaccines ↗

  npj Vaccines · 2025 · PMID 40268956
  not yet assessed
• The intratumoral balance of IgG4+ plasma cells and CD8+ T cells is associated with prognosis of intrahepatic cholangiocarcinoma after curative resection ↗

  Digestive and Liver Disease · 2025 · PMID 40307164
  not yet assessed
• Graft PD-L1 as a predictive marker for rejection in PD-1 inhibitor therapy for recurrent liver tumors after transplant: A prospective pilot trial ↗

  Liver Transplantation · 2025 · PMID 40879506
  not yet assessed
• Bile acid synthesis dysregulation in liver diseases promotes ectopic expansion of oral streptococci in the intestine ↗

  Cell Reports · 2025 · PMID 41032415
  not yet assessed
• Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia ↗

  ESMO Gastrointestinal Oncology · 2025 · PMID 41646258
  not yet assessed
• Demoralization and dignity loss in breast cancer: A network analysis and computer simulation study ↗

  Asia-Pacific Journal of Oncology Nursing · 2025 · PMID 41210322
  not yet assessed
• Cigarette defect detection based on independent feature extraction constraints ↗

  Electronics Letters · 2025
  not yet assessed
• Low-orbit satellite signal interference detection based on fast regional convolutional network and its multidimensional evaluation method ↗

  Journal of Combinatorial Mathematics and Combinatorial Computing · 2025
  not yet assessed
• FAITH trial: Feasibility and safety of anlotinib plus benmelstobart in patients with previously immunotherapy treated intermediate-to-advanced hepatocellular carcinoma—Amulticenter, single arm, prospective phase Ⅱ trial. ↗

  Journal of Clinical Oncology · 2025
  not yet assessed
• First-line rilvegostomig (rilve) plus chemotherapy (CTx) in advanced biliary tract cancer (BTC): Primary analysis of GEMINI-Hepatobiliary substudy 2 Cohort A. ↗

  Journal of Clinical Oncology · 2025
  not yet assessed
• Erratum: CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinoma ↗

  Hepatology · 2025 · PMID 39960205
  not yet assessed
• Data from ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis ↗

  2025
  not yet assessed
• Supplementary Data from ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis ↗

  2025
  not yet assessed
• Inactivation of Penicillium Expansum Spores in Water Using Discharge Plasma and Inhibition Formation of Chlorinated Disinfection Byproducts ↗

  SSRN Electronic Journal · 2025
  not yet assessed
• Use of Model-Informed Drug Development (MIDD) to Support Dose Selection of Nivolumab in Combination with Ipilimumab in Adolescent Patients with MSI-H/dMMR Metastatic Colorectal Cancer ↗

  2025
  not yet assessed
• Supplementary Figure S5 from Personalized MRD Assessment in Perisurgical ctDNA for Prognostic Prediction in Hepatocellular Carcinoma ↗

  2025
  not yet assessed
• Supplementary Figure S3 from Personalized MRD Assessment in Perisurgical ctDNA for Prognostic Prediction in Hepatocellular Carcinoma ↗

  2025
  not yet assessed
• Supplementary Table S2 from Personalized MRD Assessment in Perisurgical ctDNA for Prognostic Prediction in Hepatocellular Carcinoma ↗

  2025
  not yet assessed
• Supplementary Figure S4 from Personalized MRD Assessment in Perisurgical ctDNA for Prognostic Prediction in Hepatocellular Carcinoma ↗

  2025
  not yet assessed
• Supplementary Figure S1 from Personalized MRD Assessment in Perisurgical ctDNA for Prognostic Prediction in Hepatocellular Carcinoma ↗

  2025
  not yet assessed
• Supplementary Figure S2 from Personalized MRD Assessment in Perisurgical ctDNA for Prognostic Prediction in Hepatocellular Carcinoma ↗

  2025
  not yet assessed
• Data from Personalized MRD Assessment in Perisurgical ctDNA for Prognostic Prediction in Hepatocellular Carcinoma ↗

  2025
  not yet assessed
• Supplementary Table S1 from Personalized MRD Assessment in Perisurgical ctDNA for Prognostic Prediction in Hepatocellular Carcinoma ↗

  2025
  not yet assessed
• Coronary artery centerline extraction using a robust lightweight CNN approach ↗

  2025
  not yet assessed
• Inactivation of Penicillium expansum spores in water using discharge plasma and inhibition formation of chlorinated disinfection byproducts ↗

  Separation and Purification Technology · 2025
  not yet assessed
• Radio-genomics analysis of contrast-enhanced MRI for predicting therapeutic response to lenvatinib-based systemic therapy in hepatocellular carcinoma. ↗

  Journal of Clinical Oncology · 2025
  not yet assessed
• Multi-center Comparison of Rabeprazole and Esomeprazole Bismuth Quadruple Therapies in Treatment of Primary &amp;lt;i&amp;gt;Helicobacter pylori&amp;lt;/i&amp;gt; Infection ↗

  Science Discovery · 2025
  not yet assessed
• Auxiliary liver transplantation using otherwise-discarded liver allograft combined with associating liver partition and portal vein ligation for staged hepatectomy for unresectable colorectal liver metastases ↗

  HepatoBiliary Surgery and Nutrition · 2025 · PMID 40893759
  not yet assessed
• Reversal ALPPS ↗

  2025
  not yet assessed
• Assessing Hydropower Impacts on Flood and Drought Hazards in the Lancang–Mekong River Using CNN-LSTM Machine Learning ↗

  Water · 2025
  not yet assessed
• CTL-SSI-LAMP Platform for Rapid On-site Detection of Surgical Site Infection Post-Liver-Surgery in Abdominal Drainage Fluid Samples ↗

  SSRN Electronic Journal · 2025
  not yet assessed
• A novel approach to poliovirus vaccine neurovirulence testing: development of an enhanced 4-level scoring system ↗

  Immunobiology · 2025 · PMID 41046753
  not yet assessed
• [Analysis on the effect of subfascial anterior transposition of the ulnar nerve with vascularized fascial flap combined with intraoperative neurophysiological monitoring in the treatment of moderate to severe cubital tunnel syndrome]. ↗

  PubMed · 2025 · PMID 41255013
  not yet assessed
• Comparative analysis of the therapeutic effect of antibiotic bone cement on Wagner grade 3 or 4 diabetic foot ulcer in heel and non-heel areas: a retrospective cohort study ↗

  Frontiers in Endocrinology · 2025 · PMID 41384024
  not yet assessed
• Morphological Landscape Mapping Decodes Pathological Heterogeneity and Proteomic Programs in HCC ↗

  medRxiv · 2025
  not yet assessed
• Supplementary Table S5 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2025
  not yet assessed
• Supplementary Table S6 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2025
  not yet assessed
• Supplementary Table S4 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2025
  not yet assessed
• Supplementary Table S7 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2025
  not yet assessed
• Supplementary Table S2 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2025
  not yet assessed
• Supplementary Table S3 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2025
  not yet assessed
• Supplementary Figures S1-9 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2025
  not yet assessed
• Supplementary Table S1 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2025
  not yet assessed
• Correction: Comparative analysis of the therapeutic effect of antibiotic bone cement on Wagner grade 3 or 4 diabetic foot ulcer in heel and non-heel areas: a retrospective cohort study ↗

  Frontiers in Endocrinology · 2025 · PMID 41480365
  not yet assessed
• Multidimensional Assessment of Sex Hormone Exposure and Lung Adenocarcinoma Development in Never-Smoking Women ↗

  SSRN Electronic Journal · 2025
  not yet assessed
• Neutrophil profiling illuminates anti-tumor antigen-presenting potency ↗

  Cell · 2024 · PMID 38447573
  not yet assessed
• A blueprint for tumor-infiltrating B cells across human cancers ↗

  Science · 2024 · PMID 38696569
  not yet assessed
• CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma ↗

  Journal of Hepatology · 2024 · PMID 38403027
  not yet assessed
• Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma ↗

  Nature Communications · 2024 · PMID 38245530
  not yet assessed
• Cancer-associated fibroblasts contributed to hepatocellular carcinoma recurrence and metastasis via CD36-mediated fatty-acid metabolic reprogramming ↗

  Experimental Cell Research · 2024 · PMID 38301989
  not yet assessed
• Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma ↗

  Cellular and Molecular Immunology · 2024 · PMID 39496854
  not yet assessed
• ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis ↗

  Cancer Research · 2024 · PMID 39495239
  not yet assessed
• RECQL4 Inhibits Radiation‐Induced Tumor Immune Awakening via Suppressing the cGAS‐STING Pathway in Hepatocellular Carcinoma ↗

  Advanced Science · 2024 · PMID 38381090
  not yet assessed
• Inhibition of SIRT1 relieves hepatocarcinogenesis via alleviating autophagy and inflammation ↗

  International Journal of Biological Macromolecules · 2024 · PMID 39074701
  not yet assessed
• A <scp>Transformer‐Based</scp> microvascular invasion classifier enhances prognostic stratification in <scp>HCC</scp> following radiofrequency ablation ↗

  Liver International · 2024 · PMID 38263714
  not yet assessed
• Prolonged Survival of Neutrophils Induced by Tumor‐Derived G‐CSF/GM‐CSF Promotes Immunosuppression and Progression in Laryngeal Squamous Cell Carcinoma ↗

  Advanced Science · 2024 · PMID 39447112
  not yet assessed
• Electrochemical Dicarboxylation of Vinyl Epoxide with CO₂ for the Facile and Selective Synthesis of Diacids ↗

  Angewandte Chemie International Edition · 2024 · PMID 39731400
  not yet assessed
• CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma ↗

  Cell Death and Disease · 2024 · PMID 38287022
  not yet assessed
• Personalized MRD Assessment in Perisurgical ctDNA for Prognostic Prediction in Hepatocellular Carcinoma ↗

  Clinical Cancer Research · 2024 · PMID 39526910
  not yet assessed
• Distinct immune microenvironment of venous tumor thrombus in hepatocellular carcinoma at single-cell resolution ↗

  Hepatology · 2024 · PMID 39656099
  not yet assessed
• Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma ↗

  Journal of Gastroenterology · 2024 · PMID 38461467
  not yet assessed
• SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinoma ↗

  Cell Research · 2024 · PMID 39103523
  not yet assessed
• Mobilization and activation of tumor-infiltrating dendritic cells inhibits lymph node metastasis in intrahepatic cholangiocarcinoma ↗

  Cell Death Discovery · 2024 · PMID 38926350
  not yet assessed
• Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma ↗

  Journal of Cancer Research and Clinical Oncology · 2024 · PMID 39002018
  not yet assessed
• Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver ↗

  Nature Communications · 2024 · PMID 39551842
  not yet assessed
• Deubiquitinase UCHL1 stabilizes KDM4B to augment VEGF signaling and confer bevacizumab resistance in clear cell renal cell carcinoma ↗

  Translational Oncology · 2024 · PMID 38743986
  not yet assessed
• m5C RNA methylation: a potential mechanism for infectious Alzheimer’s disease ↗

  Frontiers in Cell and Developmental Biology · 2024 · PMID 39175875
  not yet assessed
• RNA modifications in pulmonary diseases ↗

  MedComm · 2024 · PMID 38706740
  not yet assessed
• Sintilimab plus bevacizumab followed by resection in intermediate-stage hepatocellular carcinoma: a phase Ib clinical trial with biomarker analysis ↗

  BMJ Oncology · 2024 · PMID 40046248
  not yet assessed
• Effective Antiviral Therapy Improves Immunosuppressive Activities in the Immune Microenvironment of Hepatocellular Carcinoma by Alleviating Inflammation and Fibrosis ↗

  Cancer Medicine · 2024 · PMID 39659057
  not yet assessed
• Recent advances in surgical management strategies for hepatocellular carcinoma ↗

  hLife · 2024
  not yet assessed
• Serum Galectin-9 mirrors immune-evasive microenvironment and predicts early recurrence in hepatocellular carcinoma ↗

  Gene · 2024 · PMID 39706231
  not yet assessed
• Depth of Radiographic Response as an Independent Prognostic Factor for Patients with Initially Unresectable Hepatocellular Carcinoma Receiving Hepatectomy following Targeted Therapy plus Immunotherapy ↗

  Liver Cancer · 2024 · PMID 40255871
  not yet assessed
• Long-term outcomes in hospitalized heart failure patients in China: results from the China National Heart Failure (CN-HF) registry study ↗

  European Heart Journal · 2024
  not yet assessed
• Immune persistence after different polio sequential immunization schedules in Chinese infants ↗

  npj Vaccines · 2024 · PMID 38424078
  not yet assessed
• Electrochemical Dicarboxylation of Vinyl Epoxide with CO₂ for the Facile and Selective Synthesis of Diacids ↗

  Angewandte Chemie · 2024
  not yet assessed
• Whole‐exome sequencing‐based mutational profiling of hepatocellular adenoma malignant transformation to hepatocellular carcinoma ↗

  Clinical and Experimental Pharmacology and Physiology · 2024 · PMID 38843867
  not yet assessed
• Mutation-based therapies for intrahepatic cholangiocarcinoma: new options on the horizon ↗

  Hepatoma Research · 2024
  not yet assessed
• Exploration of the carcinogenetic and immune role of CHK1 in human cancer ↗

  Journal of Cancer · 2024 · PMID 39440047
  not yet assessed
• GEMINI-Hepatobiliary: A phase 2 study of novel first-line immuno-oncology-based treatments in patients with advanced hepatobiliary cancers. ↗

  Journal of Clinical Oncology · 2024
  not yet assessed
• ZSAB-TOP: A phase 2 trial of tislelizumab (TIS) and ociperlimab (OCI) combined with gemcitabine and cisplatin (GemCis) as the first-line treatment for advanced biliary tract cancer (BTC). ↗

  Journal of Clinical Oncology · 2024
  not yet assessed
• Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis ↗

  Molecular Cancer · 2024 · PMID 38424621
  not yet assessed
• A single-arm, multi-center phase II study of tislelizumab combined with lenvatinib and GEMOX as conversion therapy in potentially resectable locally advanced biliary tract cancer (ZSAB-TransGOLP): A primary analysis. ↗

  Journal of Clinical Oncology · 2024
  not yet assessed
• [Preliminary application of antibiotic bone cement directly inducing skin regeneration technology in repairing of wound in lateral toe flap donor area]. ↗

  PubMed · 2024 · PMID 38632069
  not yet assessed
• Abstract 1515: Tertiary lymphoid structures restrain cancer evolution by supporting stem-like CD8+ T cells for sustained anti-tumor immunity ↗

  Cancer Research · 2024
  not yet assessed
• Integrated Molecular Characterization of Sarcomatoid Hepatocellular Carcinoma ↗

  SSRN Electronic Journal · 2024
  not yet assessed
• Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma ↗

  UNC Libraries · 2024
  not yet assessed
• Supplementary Table S7 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Figures S1-9 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Table S5 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Table S7 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Table S6 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Table S2 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Table S2 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Table S3 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Table S5 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Table S3 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Figures S1-9 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Table S4 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Table S1 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Table S4 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Table S1 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• Supplementary Table S6 from An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma ↗

  2024
  not yet assessed
• &lt;b&gt;1-hour postload glucose is a more sensitive marker of impaired &lt;/b&gt;&lt;b&gt;β-cell function&lt;/b&gt;&lt;b&gt;than 2-hour postload glucose&lt;/b&gt; ↗

  2024
  not yet assessed
• Principles of Robotic Surgery ↗

  2024
  not yet assessed
• Antisera-Neutralizing Capacity of a Highly Evolved Type 2 Vaccine-Derived Poliovirus from an Immunodeficient Patient ↗

  Viruses · 2024 · PMID 39599874
  not yet assessed
• Advancing Drug Development in Relapsed and Refractory Multiple Myeloma (RRMM): Assessing the Safety and Efficacy Landscape Utilizing Model-Based Meta-Analysis ↗

  2024
  not yet assessed
• Integrated molecular characterization of sarcomatoid hepatocellular carcinoma ↗

  Clinical and Molecular Hepatology · 2024 · PMID 39657751
  not yet assessed
• Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma ↗

  Nature Metabolism · 2023 · PMID 36593272
  not yet assessed
• Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial ↗

  The Lancet · 2023 · PMID 37871608
  not yet assessed
• CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor ↗

  Cell Discovery · 2023 · PMID 36878933
  not yet assessed
• An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte–tumor cell crosstalk, local immunosuppression and tumor progression ↗

  Cell Research · 2023 · PMID 37337030
  not yet assessed
• A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights ↗

  HepatoBiliary Surgery and Nutrition · 2023 · PMID 37124695
  not yet assessed
• Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study ↗

  Signal Transduction and Targeted Therapy · 2023 · PMID 36928584
  not yet assessed
• Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation ↗

  Hepatology International · 2023 · PMID 37031334
  not yet assessed
• Spatial-temporal patterns of urban expansion by land use/ land cover transfer in China ↗

  Ecological Indicators · 2023
  not yet assessed
• A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma ↗

  Cell Discovery · 2023 · PMID 36650126
  not yet assessed
• Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy ↗

  Oncogene · 2023 · PMID 37420030
  not yet assessed
• An Inflammatory Checkpoint Generated by <i>IL1RN</i> Splicing Offers Therapeutic Opportunity for <i>KRAS</i> -Mutant Intrahepatic Cholangiocarcinoma ↗

  Cancer Discovery · 2023 · PMID 37486241
  not yet assessed
• Single-cell and spatial architecture of primary liver cancer ↗

  Communications Biology · 2023 · PMID 37985711
  not yet assessed
• Association of <i>BRAF</i> Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma ↗

  JAMA Network Open · 2023 · PMID 36867406
  not yet assessed
• Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis ↗

  Cell Death and Disease · 2023 · PMID 36732324
  not yet assessed
• Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitment ↗

  Biomedicine & Pharmacotherapy · 2023 · PMID 36940618
  not yet assessed
• MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathway ↗

  Clinical Immunology · 2023 · PMID 37717672
  not yet assessed
• Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version) ↗

  Journal of Clinical and Translational Hepatology · 2023 · PMID 38161496
  not yet assessed
• Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1 ↗

  Hepatology International · 2023 · PMID 37115456
  not yet assessed
• Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma ↗

  World Journal of Surgical Oncology · 2023 · PMID 36899373
  not yet assessed
• Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinoma ↗

  International Immunopharmacology · 2023 · PMID 37494837
  not yet assessed
• The SIRT7-mediated deacetylation of CHD1L amplifies HIF-2α-dependent signal that drives renal cell carcinoma progression and sunitinib resistance ↗

  Cell & Bioscience · 2023 · PMID 37691108
  not yet assessed
• Effectiveness and safety of lenvatinib plus anti‐programmed death‐1 antibodies in patients with hepatocellular carcinoma: A <scp>real‐world</scp> cohort study ↗

  Cancer Medicine · 2023 · PMID 36790032
  not yet assessed
• Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6+ CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinoma ↗

  Frontiers in Oncology · 2023 · PMID 37593098
  not yet assessed
• m6A methylation: a potential key player in understanding and treating COVID-2019 infection ↗

  Cell Death Discovery · 2023 · PMID 37596265
  not yet assessed
• The reconstruction of fingertip injury by mini hallux toenail flap pedicled with the hallux transverse artery and toe pulp vein transplantation technique based on the equivalent design theory ↗

  BMC Surgery · 2023 · PMID 37568142
  not yet assessed
• Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy ↗

  Frontiers in Oncology · 2023 · PMID 36910622
  not yet assessed
• Prognosis of spontaneously ruptured hepatocellular carcinoma: a propensity score matching study ↗

  Journal of Cancer Research and Clinical Oncology · 2023 · PMID 37154926
  not yet assessed
• A Randomized, Single‐Dose, Parallel‐Controlled Phase 1 Clinical Comparison of an Omalizumab Biosimilar Candidate with Reference Omalizumab in Healthy Chinese Male Volunteers ↗

  Clinical Pharmacology in Drug Development · 2023 · PMID 38053476
  not yet assessed
• The development and prospects of liver surgery ↗

  Clinical Surgical Oncology · 2023
  not yet assessed
• Evaluation of the immunization effectiveness of bOPV booster immunization and IPV revaccination ↗

  npj Vaccines · 2023 · PMID 36934085
  not yet assessed
• Construction and study of a three-dimensional visualization model of superficial temporal artery branches: With an explicatory case ↗

  Asian Journal of Surgery · 2023 · PMID 38065731
  not yet assessed
• Sintilimab combined with bevacizumab biosimilar as a conversion therapy in potentially resectable intermediate-stage hepatocellular carcinoma (HCC): Updated results of a phase II trial. ↗

  Journal of Clinical Oncology · 2023
  not yet assessed
• The efficacy and safety of toripalimab combined with sorafenib for unresectable hepatocellular carcinoma: An open-label, prospective, single-arm phase II study. ↗

  Journal of Clinical Oncology · 2023
  not yet assessed
• Donafenib combined with anti-PD-1 antibody and transarterial chemoembolization (TACE) as first-line (1L) treatment for unresectable/advanced hepatocellular carcinoma (HCC). ↗

  Journal of Clinical Oncology · 2023
  not yet assessed
• Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Cancer-derived exosomal circTMEM56 sensitize HCC radiotherapy by augment cGAS-STING pathway in dendritic cells ↗

  Research Square · 2023
  not yet assessed
• Data from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Figure from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Figure from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Data from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Immune Persistence After Different Polio Sequential Immunization Schedules in Chinese Infants ↗

  SSRN Electronic Journal · 2023
  not yet assessed
• Immune Persistence after Different Polio Sequential Immunization Schedules in Chinese Infants ↗

  Research Square · 2023
  not yet assessed
• First Implementation of Full-Workflow Automation for Online Adaptive Radiotherapy of Nasopharyngeal Carcinoma ↗

  International Journal of Radiation Oncology*Biology*Physics · 2023
  not yet assessed
• Data from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Figures S1-9 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table S3 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table S1 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table S6 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table S3 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table S5 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table S7 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table S1 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table S4 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table S2 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table S7 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table S6 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Figures S1-9 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Data from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table S2 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table S5 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• Supplementary Table S4 from An Inflammatory Checkpoint Generated by &lt;i&gt;IL1RN&lt;/i&gt; Splicing Offers Therapeutic Opportunity for &lt;i&gt;KRAS&lt;/i&gt;-Mutant Intrahepatic Cholangiocarcinoma ↗

  2023
  not yet assessed
• [Clinical effects of superficial temporal artery lobulated perforator flaps in repairing skin and soft tissue defects after temporal tumor resection]. ↗

  PubMed · 2023 · PMID 37805768
  not yet assessed
• IMbrave050: Phase-3-Studie zur adjuvanten Behandlung mit Atezolizumab+Bevacizumab im Vergleich zur aktiven Überwachung bei Patienten mit hepatozellulärem Karzinom, bei denen nach einer Resektion oder Ablation ein hohes Risiko für ein Wiederauftreten der Krankheit besteht ↗

  Zeitschrift für Gastroenterologie · 2023
  not yet assessed
• Additional file 4 of The SIRT7-mediated deacetylation of CHD1L amplifies HIF-2α-dependent signal that drives renal cell carcinoma progression and sunitinib resistance ↗

  Figshare · 2023
  not yet assessed
• Additional file 2 of The SIRT7-mediated deacetylation of CHD1L amplifies HIF-2α-dependent signal that drives renal cell carcinoma progression and sunitinib resistance ↗

  Figshare · 2023
  not yet assessed
• IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment ↗

  Cancer Discovery · 2022 · PMID 35412588
  not yet assessed
• Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition) ↗

  HepatoBiliary Surgery and Nutrition · 2022 · PMID 35464283
  not yet assessed
• Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective ↗

  Clinical and Molecular Hepatology · 2022 · PMID 36545708
  not yet assessed
• Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack ↗

  Hepatology · 2022 · PMID 35043976
  not yet assessed
• Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma ↗

  Nature Communications · 2022 · PMID 35347134
  not yet assessed
• PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma ↗

  Journal of Hepatology · 2022 · PMID 35219791
  not yet assessed
• CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma ↗

  Cell Death and Disease · 2022 · PMID 35411000
  not yet assessed
• CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma ↗

  Cancer Research · 2022 · PMID 35045986
  not yet assessed
• Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling ↗

  Gut Microbes · 2022 · PMID 36093568
  not yet assessed
• Tumor‐derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression ↗

  Hepatology · 2022 · PMID 35106794
  not yet assessed
• Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) ↗

  Liver Cancer · 2022 · PMID 35978596
  not yet assessed
• Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma ↗

  Cancer Discovery · 2022 · PMID 35853232
  not yet assessed
• Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma ↗

  Annals of Surgical Oncology · 2022 · PMID 36178565
  not yet assessed
• Multiplexed nanomaterial-assisted laser desorption/ionization for pan-cancer diagnosis and classification ↗

  Nature Communications · 2022 · PMID 35105875
  not yet assessed
• Proteogenomic characterization of cholangiocarcinoma ↗

  Hepatology · 2022 · PMID 35716043
  not yet assessed
• Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study ↗

  BJS Open · 2022 · PMID 36125345
  not yet assessed
• Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma ↗

  Hepatology · 2022 · PMID 35243663
  not yet assessed
• Dissecting Intra-Tumoral Changes Following Immune Checkpoint Blockades in Intrahepatic Cholangiocarcinoma via Single-Cell Analysis ↗

  Frontiers in Immunology · 2022 · PMID 35558087
  not yet assessed
• Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence ↗

  Signal Transduction and Targeted Therapy · 2022 · PMID 35078970
  not yet assessed
• The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion ↗

  Hepatology International · 2022 · PMID 36418844
  not yet assessed
• Criteria for identifying potentially resectable patients with initially oncologically unresectable hepatocellular carcinoma before treatment with lenvatinib plus an anti–PD–1 antibody ↗

  Frontiers in Immunology · 2022 · PMID 36505445
  not yet assessed
• CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis ↗

  Clinical and Translational Medicine · 2022 · PMID 35384345
  not yet assessed
• Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study ↗

  Frontiers in Oncology · 2022 · PMID 36505772
  not yet assessed
• Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma ↗

  Frontiers in Immunology · 2022 · PMID 35371079
  not yet assessed
• Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying <i>FGFR2</i> fusions or rearrangements: A phase <scp>II</scp> study ↗

  Cancer Medicine · 2022 · PMID 36127767
  not yet assessed
• Transcatheter arterial embolization-salvaged ALPPS, a novel ALPPS procedure especially for patients with hepatocellular carcinoma and severe fibrosis/cirrhosis ↗

  HepatoBiliary Surgery and Nutrition · 2022 · PMID 36016751
  not yet assessed
• High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma ↗

  Journal of Clinical Laboratory Analysis · 2022 · PMID 35089611
  not yet assessed
• <scp>SQSTM1</scp>/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial–mesenchymal transition and mitochondrial function maintenance ↗

  Cancer Medicine · 2022 · PMID 35676831
  not yet assessed
• Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis ↗

  Surgical Endoscopy · 2022 · PMID 36076103
  not yet assessed
• Peripheral naïve CD8 ⁺ T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study ↗

  癌症：英文版 · 2022 · PMID 35994567
  not yet assessed
• Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive procedures ↗

  Hepatology International · 2022 · PMID 36258065
  not yet assessed
• Weakly supervised semantic segmentation of histological tissue via attention accumulation and pixel-level contrast learning ↗

  Physics in Medicine and Biology · 2022 · PMID 36577142
  not yet assessed
• The Safety Profile of Hepatectomy Following Preoperative Systemic Therapy with Lenvatinib Plus Anti-PD-1 Antibodies Versus Hepatectomy Alone in Patients With Hepatocellular Carcinoma ↗

  Annals of Surgery Open · 2022 · PMID 37601608
  not yet assessed
• Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges ↗

  Journal of Oncology · 2022 · PMID 36405248
  not yet assessed
• Severe coronary artery spasm during left atrial appendage closure plus catheter ablation for atrial fibrillation: case presentation ↗

  BMC Cardiovascular Disorders · 2022 · PMID 35148671
  not yet assessed
• Whole-Exome Sequencing Identified Genes Responsible for Thoracic Aortic Aneurysms and Dissections in three Chinese Families ↗

  Frontiers in Genetics · 2022 · PMID 35754816
  not yet assessed
• Comprehensive analysis of complement-associated molecular features in hepatocellular carcinoma ↗

  Acta Biochimica et Biophysica Sinica · 2022 · PMID 35929594
  not yet assessed
• MILLET (BRASSICA NAPUS L.) ROTATION MODEL PROMOTED THE YIELD OF MILLET BY IMPROVING THE FUNGAL COMMUNITY STRUCTURE IN DRYLANDS IN CHINA ↗

  Applied Ecology and Environmental Research · 2022
  not yet assessed
• Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection ↗

  Molecular Cancer · 2022 · PMID 35690859
  not yet assessed
• Publisher Correction: Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma ↗

  Nature Communications · 2022 · PMID 35581192
  not yet assessed
• Correction to: Consensus on the secondary prevention of primary liver cancer ↗

  Hepatology International · 2022 · PMID 35020155
  not yet assessed
• Reply ↗

  Hepatology · 2022 · PMID 35352844
  not yet assessed
• Molecular Features and Clinical Implications of Perineural Invasion in Intrahepatic Cholangiocarcinoma ↗

  SSRN Electronic Journal · 2022
  not yet assessed
• Evaluation of the immunization effectiveness of a bOPV booster immunization at 48 months of age after basic polio sequential immunization with bOPV and IPV ↗

  Research Square · 2022
  not yet assessed
• Additional file 1 of Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection ↗

  Open MIND · 2022
  not yet assessed
• Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma ↗

  Journal of Hepatology · 2021 · PMID 34793865
  not yet assessed
• Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations ↗

  Liver Cancer · 2021 · PMID 34414120
  not yet assessed
• Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma ↗

  Nature Communications · 2021 · PMID 34215748
  not yet assessed
• Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3 ↗

  Journal for ImmunoTherapy of Cancer · 2021 · PMID 33692217
  not yet assessed
• Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis ↗

  Cell Death and Disease · 2021 · PMID 33707417
  not yet assessed
• Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell‐free DNA fragmentomics ↗

  Hepatology · 2021 · PMID 34954829
  not yet assessed
• PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology ↗

  Frontiers in Immunology · 2021 · PMID 33841428
  not yet assessed
• Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis ↗

  Biomarker Research · 2021 · PMID 33743822
  not yet assessed
• Association of <i>KRAS</i> Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma ↗

  JAMA Surgery · 2021 · PMID 34730772
  not yet assessed
• Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF‐kB signaling pathways synergistically ↗

  Clinical and Translational Medicine · 2021 · PMID 33634982
  not yet assessed
• LINC01133 promotes hepatocellular carcinoma progression by sponging miR‐199a‐5p and activating annexin A2 ↗

  Clinical and Translational Medicine · 2021 · PMID 34047479
  not yet assessed
• CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma ↗

  Frontiers in Immunology · 2021 · PMID 34526987
  not yet assessed
• Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study ↗

  Molecular Oncology · 2021 · PMID 34543520
  not yet assessed
• Characterization of immune infiltration in sarcomatoid hepatocellular carcinoma ↗

  Aging · 2021 · PMID 34081621
  not yet assessed
• Immune checkpoint inhibitor plus tyrosine kinase inhibitor for unresectable hepatocellular carcinoma in the real world ↗

  Annals of Translational Medicine · 2021 · PMID 33987350
  not yet assessed
• Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma ↗

  Biomarker Research · 2021 · PMID 34930486
  not yet assessed
• BRG1 regulates lipid metabolism in hepatocellular carcinoma through the PIK3AP1/PI3K/AKT pathway by mediating GLMP expression ↗

  Digestive and Liver Disease · 2021 · PMID 34158256
  not yet assessed
• Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine ↗

  Frontiers in Oncology · 2021 · PMID 34327143
  not yet assessed
• Plasma MicroRNA Panel Predicts Early Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation ↗

  Journal of Cancer · 2021 · PMID 34729120
  not yet assessed
• Genomic evolution and the impact of SLIT2 mutation in relapsed intrahepatic cholangiocarcinoma ↗

  Hepatology · 2021 · PMID 34543483
  not yet assessed
• Efficacy and safety of sirolimus early conversion protocol in liver transplant patients with hepatocellular carcinoma: A single-arm, multicenter, prospective study ↗

  Hepatobiliary & pancreatic diseases international · 2021 · PMID 34583911
  not yet assessed
• Development and validation of a non-invasive model for diagnosing HBV-related liver cirrhosis ↗

  Clinica Chimica Acta · 2021 · PMID 34748781
  not yet assessed
• Multiple Omics Integration Reveals Key Circular RNAs in Hepatocellular Carcinoma ↗

  Frontiers in Oncology · 2021 · PMID 34094907
  not yet assessed
• TM2D1 contributes the epithelial-mesenchymal transition of hepatocellular carcinoma via modulating AKT/β-catenin axis. ↗

  PubMed · 2021 · PMID 33948373
  not yet assessed
• A High-Accuracy Model Based on Plasma miRNAs Diagnoses Intrahepatic Cholangiocarcinoma: A Single Center with 1001 Samples ↗

  Diagnostics · 2021 · PMID 33805513
  not yet assessed
• Increase of Portal Vein Pressure Gradient After Hepatectomy Predicts Post-operative Liver Dysfunction ↗

  Surgical Innovation · 2021 · PMID 33993786
  not yet assessed
• Newly detected liver nodules with a history of colorectal cancer: are they metastatic? Review of 2,632 cases in a single center ↗

  Annals of Translational Medicine · 2021 · PMID 34422991
  not yet assessed
• 948P Predicting the efficacy of lenvatinib plus anti-PD-1 antibodies in unresectable hepatocellular carcinoma (uHCC) using radiomics features of tumors extracted from baseline MRI ↗

  Annals of Oncology · 2021
  not yet assessed
• Spatially-resolved transcriptomics analyses of invasive fronts in solid tumors ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2021
  not yet assessed
• Erratum: Correction: Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? (PLoS pathogens (2020) 16 5 (e1008421))

  PLoS Pathogens · 2021
  not yet assessed
• [Application of Zunyi's Suture Method for donor site of anterolateral thigh flap]. ↗

  PubMed · 2021 · PMID 33855833
  not yet assessed
• Single-Cell Transcriptomic Analysis Reveals Two Molecularly and Clinically Distinct Subtypes of Intrahepatic Cholangiocarcinoma ↗

  Research Square · 2021
  not yet assessed
• Abstract 1456: The safety and efficacy of lenvatinib in preventing early recurrence after liver transplantation for hepatocellular carcinoma beyond Milan criteria: A single-center, retrospective, propensity-matched study ↗

  Cancer Research · 2021
  not yet assessed
• Author response for "Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study" ↗

  2021
  not yet assessed
• 50P Efficacy and safety of pemigatinib in Chinese patients with unresectable, advanced/ recurrent or metastatic intrahepatic cholangiocarcinoma with FGFR2 fusion or rearrangement that failed to prior systemic therapy ↗

  Annals of Oncology · 2021
  not yet assessed
• P-L01 Newly detected liver nodules with a history of colorectal cancer: are they metastasis? ↗

  British journal of surgery · 2021
  not yet assessed
• Targeted therapy for hepatocellular carcinoma ↗

  Signal Transduction and Targeted Therapy · 2020 · PMID 32782275
  not yet assessed
• 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights ↗

  HepatoBiliary Surgery and Nutrition · 2020 · PMID 32832496
  not yet assessed
• A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements ↗

  Liver Cancer · 2020 · PMID 32647629
  not yet assessed
• Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning ↗

  Gut · 2020 · PMID 32998878
  not yet assessed
• Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma ↗

  Cell Death and Disease · 2020 · PMID 32709873
  not yet assessed
• CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5‐LSD1‐NF‐κB oncogenic signaling ↗

  Clinical and Translational Medicine · 2020 · PMID 33377659
  not yet assessed
• DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury ↗

  Cellular and Molecular Immunology · 2020 · PMID 32203191
  not yet assessed
• The anti-inflammatory potential of protein-bound anthocyanin compounds from purple sweet potato in LPS-induced RAW264.7 macrophages ↗

  Food Research International · 2020 · PMID 33233226
  not yet assessed
• Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma ↗

  Theranostics · 2020 · PMID 32483468
  not yet assessed
• Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy ↗

  Theranostics · 2020 · PMID 33204320
  not yet assessed
• The aberrant expression of rhythm genes affects the genome instability and regulates the cancer immunity in pan‐cancer ↗

  Cancer Medicine · 2020 · PMID 31927791
  not yet assessed
• Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors ↗

  Liver Transplantation · 2020 · PMID 32897657
  not yet assessed
• SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms ↗

  Oncogene · 2020 · PMID 32005974
  not yet assessed
• The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome ↗

  Clinical and Translational Medicine · 2020 · PMID 32508015
  not yet assessed
• ROR-α-1 inhibits the proliferation, invasion, and migration of hepatocellular carcinoma MHCC97H via downregulation of chemokine CXCL5 ↗

  Cytokine · 2020 · PMID 32058275
  not yet assessed
• GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma. ↗

  PubMed · 2020 · PMID 33294262
  not yet assessed
• Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization ↗

  Clinica Chimica Acta · 2020 · PMID 32979338
  not yet assessed
• 1017TiP KEYNOTE-937 trial in progress: adjuvant pembrolizumab in patients with hepatocellular carcinoma (HCC) and complete radiologic response after surgical resection or local ablation ↗

  Annals of Oncology · 2020
  not yet assessed
• Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma ↗

  Technology in Cancer Research & Treatment · 2020 · PMID 32613904
  not yet assessed
• Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains ↗

  Human Vaccines & Immunotherapeutics · 2020 · PMID 32118517
  not yet assessed
• AURKA Increase the Chemosensitivity of Colon Cancer Cells to Oxaliplatin by Inhibiting the TP53‐Mediated DNA Damage Response Genes ↗

  BioMed Research International · 2020 · PMID 32851091
  not yet assessed
• Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma ↗

  BMC Cancer · 2020 · PMID 32736575
  not yet assessed
• Tfr-Tfh index: A new predicator for recurrence of hepatocellular carcinoma patients with HBV infection after curative resection ↗

  Clinica Chimica Acta · 2020 · PMID 33080261
  not yet assessed
• Sensitivity of ASPP and P-gp to neoadjuvant chemotherapy combined with gene therapy in locally advanced cervical cancer. ↗

  PubMed · 2020 · PMID 31424649
  not yet assessed
• A retrospective cohort study of preoperative lipid indices and their impact on new‐onset diabetes after liver transplantation ↗

  Journal of Clinical Laboratory Analysis · 2020 · PMID 31981248
  not yet assessed
• Diagnosis Value of Combined Detection of Serum SF, CEA and CRP in Non-Small Cell Lung Cancer

  DOAJ (DOAJ: Directory of Open Access Journals) · 2020
  not yet assessed
• Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2020
  not yet assessed
• Initially unresectable hepatocellular carcinoma treated by combination therapy of tyrosine kinase inhibitor and anti-PD-1 antibody followed by resection. ↗

  Journal of Clinical Oncology · 2020
  not yet assessed
• Effect of postoperative apatinib treatment after resection of hepatocellular carcinoma with portal vein invasion: A phase II study. ↗

  Journal of Clinical Oncology · 2020
  not yet assessed
• Development of a novel liquid biopsy test to diagnose and locate gastrointestinal cancers. ↗

  Journal of Clinical Oncology · 2020
  not yet assessed
• Effects of exosomal circular RNA-100338 derived from hepatocellular carcinoma on angiogenesis of human umbilical vein endothelial cells ↗

  Zhonghua shiyan waike zazhi · 2020
  not yet assessed
• [Clinical effects of modified fascia flap from cutaneous branch of dorsal metacarpal artery in repairing the wound at the proximal and middle finger segments]. ↗

  PubMed · 2020 · PMID 32829615
  not yet assessed
• Abstract LB-309: Comprehensive genomic insights into dynamic mechanism underlying the development of non-malignant human liver disease into hepatocellular carcinoma ↗

  Cancer Research · 2020
  not yet assessed
• [Study on the value of serum des-γ-carboxy prothrombin in predicting hepatocellular carcinoma recurrence after liver transplantation]. ↗

  PubMed · 2020 · PMID 33256276
  not yet assessed
• Safety and effectiveness of individualized transscleral cyclophotocoagulation as the initial surgical intervention for medically uncontrolled intraocular pressure in glaucoma after blunt trauma

  Linchuang Yixueyanjiu yu Shijian · 2020
  not yet assessed
• Additional file 3 of Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma ↗

  Figshare · 2020
  not yet assessed
• Additional file 2 of Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma ↗

  Figshare · 2020
  not yet assessed
• Additional file 8 of Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma ↗

  Figshare · 2020
  not yet assessed
• Additional file 1 of Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma ↗

  Figshare · 2020
  not yet assessed
• Additional file 5 of Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma ↗

  Figshare · 2020
  not yet assessed
• Additional file 2 of Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis ↗

  Open MIND · 2020
  not yet assessed
• Additional file 9 of Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma ↗

  Figshare · 2020
  not yet assessed
• Additional file 3 of Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis ↗

  Figshare · 2020
  not yet assessed
• Additional file 7 of Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma ↗

  Figshare · 2020
  not yet assessed
• Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma ↗

  Gut · 2019 · PMID 31358576
  not yet assessed
• Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma ↗

  Journal of Hepatology · 2019 · PMID 31887370
  not yet assessed
• A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA ↗

  Cancer Letters · 2019 · PMID 30790682
  not yet assessed
• CircRNA-100338 Is Associated With mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma ↗

  Frontiers in Oncology · 2019 · PMID 31157168
  not yet assessed
• Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors ↗

  Theranostics · 2019 · PMID 31367249
  not yet assessed
• Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score‐matched survival analysis ↗

  Cancer Medicine · 2019 · PMID 31566899
  not yet assessed
• Endovascular Reconstruction from Aortic Valve to Aortic Arch Using One-Piece Valved-Fenestrated Stent Graft with a Branch: A Proof-of-Concept Study ↗

  The Heart Surgery Forum · 2019 · PMID 31596716
  not yet assessed
• Screening and identification of a human domain antibody against Brucella abortus VirB5 ↗

  Acta Tropica · 2019 · PMID 31103700
  not yet assessed
• Pediatric inguinal hernia treated by single-port laparoscopic water injection hernia crochet needle. ↗

  Videosurgery and Other Miniinvasive Techniques · 2019 · PMID 32117511
  not yet assessed
• In Situ Normothermic Regional Perfusion for Liver Donation From China Category III (Organ Donation After Brain Death Followed by Circulatory Death): A Single-Center Cohort Study ↗

  Experimental and Clinical Transplantation · 2019 · PMID 31617836
  not yet assessed
• Nanomaterials augmented LDI-TOF-MS for hepatocellular carcinoma diagnosis and classification ↗

  Annals of Oncology · 2019
  not yet assessed
• MA13.11 A Randomized Phase III Study of Cisplatin-Polymeric Micelle Paclitaxel vs Cisplatin-Solvent-Based Paclitaxel in 1st Line Advanced NSCLC ↗

  Journal of Thoracic Oncology · 2019
  not yet assessed
• Promoting invasive ability of hepatocellular carcinoma by co-culture of exosomes from tumor cells with high metastatic potential ↗

  Zhonghua shiyan waike zazhi · 2019
  not yet assessed
• structure of Mutant S44P of maltooligosyltrehalose synthase from Arthrobacter ramosus ↗

  2019
  not yet assessed
• Immune persistence and efficacy of boosting dose of inactivated polio virus vaccine derived from the Sabin strain with intradermal immunization in Wistar rats.

  Bingdu xuebao · 2019
  not yet assessed
• Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma ↗

  Annals of Surgery · 2018 · PMID 29995681
  not yet assessed
• TNF receptor‐associated factor 1 as a biomarker for assessment of non‐small cell lung cancer metastasis and overall survival ↗

  The Clinical Respiratory Journal · 2018 · PMID 29528567
  not yet assessed
• Assessment of lingual sentinel lymph nodes metastases using dual-modal indirect CT/MR lymphography with gold–gadolinium-based nanoprobes in a tongue VX₂carcinoma model ↗

  Acta Oto-Laryngologica · 2018 · PMID 29513120
  not yet assessed
• 5-Hydroxymethylcytosines from Circulating Cell-free DNA as Diagnostic and Prognostic Markers for Hepatocellular Carcinoma ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2018
  not yet assessed
• Renal Transplantation of Discolored Kidneys from Donors with Rhabdomyolysis and Acute Kidney Injury ↗

  Transplantation · 2018
  not yet assessed
• Repair of skin and soft tissue defects at ankle and donor site with relaying reversed peroneal artery perforator flaps ↗

  Zhonghua chuangshang zazhi · 2018
  not yet assessed
• Incidence and outcomes of acute kidney injury in patients with hepatocellular carcinoma after liver transplantation ↗

  Journal of Cancer Research and Clinical Oncology · 2017 · PMID 28289896
  not yet assessed
• Kidney transplantation from donors with rhabdomyolysis and acute renal failure ↗

  Clinical Transplantation · 2017 · PMID 28564273
  not yet assessed
• Kidney Transplantation from Donors Died of Organophosphate Poisoning ↗

  Transplantation · 2017
  not yet assessed
• Development and validation of a survival calculator for hepatocellular carcinoma patients undergoing liver transplantation: the Metroticket 2.0 model ↗

  Journal of Hepatology · 2017
  not yet assessed
• Additional file 1: Table S1. of Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B ↗

  INDIGO (University of Illinois at Chicago) · 2017
  not yet assessed
• Bilateral High Grade Serous Carcinoma of Ovary: A Targeted Next Generation Sequencing Study

  Touro Scholar (Touro College) · 2017
  not yet assessed
• Interaction between missing in metastasis B and caveolin-1 in hepatocellular carcinoma ↗

  Zhonghua shiyan waike zazhi · 2017
  not yet assessed
• Neutrophil infiltration mediated by CXCL5 accumulation in the laryngeal squamous cell carcinoma microenvironment: A mechanism by which tumour cells escape immune surveillance ↗

  Clinical Immunology · 2016 · PMID 27876461
  not yet assessed
• Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR‐mediated VEGF production ↗

  Molecular Carcinogenesis · 2016 · PMID 27996164
  not yet assessed
• Phase 3 Trial of a Sabin Strain–Based Inactivated Poliovirus Vaccine ↗

  The Journal of Infectious Diseases · 2016 · PMID 27658691
  not yet assessed
• Organ Donation and Transplantation From Donors With Systemic Infection: A Single-Center Experience ↗

  Transplantation Proceedings · 2016 · PMID 27742320
  not yet assessed
• Short-Term Dynamic Observation of the Color Change and Enhancement Effect of Polyethylenimine-Entrapped Gold Nanoparticles Used for Indirect Lymphography ↗

  ORL · 2016 · PMID 27234613
  not yet assessed
• Long-term observation of indirect lymphography using gadolinium-loaded polyethylenimine-entrapped gold nanoparticles as a dual mode CT/MR contrast agent for rabbit lingual sentinel lymph node identification ↗

  Acta Oto-Laryngologica · 2016 · PMID 27577609
  not yet assessed
• Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats ↗

  Human Vaccines & Immunotherapeutics · 2016 · PMID 27558963
  not yet assessed
• CHD4 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor cell proliferation ↗

  2016
  not yet assessed
• Association between helicobacter pylori infection and carcinoma of the larynx or pharynx ↗

  Head & Neck · 2015 · PMID 26316145
  not yet assessed
• Effect of interleukin‐2 receptor antagonists on new‐onset diabetes after liver transplantation: A retrospective cohort study ↗

  Journal of Diabetes · 2015 · PMID 26588180
  not yet assessed
• Predicting the Twenty-Year Risk of Cardiovascular Disease in Middle-Aged Chinese. ↗

  International Journal of Epidemiology · 2015
  not yet assessed
• [Effect of blood purification on precision of measurement of hemodianics with thernodilution method in patients with septic shock]. ↗

  PubMed · 2015 · PMID 26003651
  not yet assessed
• Neoalbaconol induces cell death through necroptosis by regulating RIPK-dependent autocrine TNFα and ROS production ↗

  Oncotarget · 2014 · PMID 25575821
  not yet assessed
• Gastroesophageal reflux and carcinoma of larynx or pharynx: a meta-analysis ↗

  Acta Oto-Laryngologica · 2014 · PMID 25131391
  not yet assessed
• Hyperosmolar nonketotic hyperglycemic coma induced by methylprednisolone pulse therapy for acute rejection after liver transplantation: a case report and review of the literature ↗

  Transplant Research and Risk Management · 2014
  not yet assessed
• One center's experiences of 101 cases of kidney transplants from cardiac death donors. ↗

  Experimental and Clinical Transplantation · 2014 · PMID 25095708
  not yet assessed
• Comprehensive treatment of acute-on-chronic liver failure in a patient with hepatitis B: a case report ↗

  Frontiers of Medicine · 2014 · PMID 24810647
  not yet assessed
• The heterogeneity and clinical relevance of circulating tumor-initiating cells in hepatocellular carcinoma using an integrated immunomagnetic-microfluidic platform. ↗

  Journal of Clinical Oncology · 2014
  not yet assessed
• Long-Term Efficacy of Simultaneous Pancreas and Kidney Transplantation in Liver Transplant Recipient. ↗

  Transplantation · 2014
  not yet assessed
• Clinical analysis of 130 cases of donation after citizens death in China ↗

  Chineae Journal of Organ Transplantation · 2014
  not yet assessed
• Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection ↗

  Journal of Cancer Research and Clinical Oncology · 2013 · PMID 23377952
  not yet assessed
• Effects of imbalance of dynamic and static forces on the disc degeneration of cervical spine at different levels in rats: a micro-CT morphology and histology study

  2013
  not yet assessed
• Relationship clinical research between esophagitis and alendronate treatment on postmenopausal osteoporosis

  Zhongguo linchuang baojian zazhi · 2013
  not yet assessed
• [Combined modality therapy for recurrent hepatocellular carcinoma following liver transplantation]. ↗

  PubMed · 2013 · PMID 24052958
  not yet assessed
• Decreased Selenium-Binding Protein 1 Enhances Glutathione Peroxidase 1 Activity and Downregulates HIF-1α to Promote Hepatocellular Carcinoma Invasiveness ↗

  Clinical Cancer Research · 2012 · PMID 22512980
  not yet assessed
• Activation of PI3K/AKT and MAPK Pathway through a PDGFRβ-Dependent Feedback Loop Is Involved in Rapamycin Resistance in Hepatocellular Carcinoma ↗

  PLoS ONE · 2012 · PMID 22428038
  not yet assessed
• Low Level of Low-Density Lipoprotein Receptor-Related Protein 1 Predicts an Unfavorable Prognosis of Hepatocellular Carcinoma after Curative Resection ↗

  PLoS ONE · 2012 · PMID 22427881
  not yet assessed
• Preclinical study of using multiphoton microscopy to diagnose liver cancer and differentiate benign and malignant liver lesions ↗

  Journal of Biomedical Optics · 2012 · PMID 22463036
  not yet assessed
• Prognostic significance and clinical relevance of Sprouty 2 protein expression in human hepatocellular carcinoma ↗

  Hepatobiliary & pancreatic diseases international · 2012 · PMID 22484587
  not yet assessed
• Perioperative nutrition support therapy for combined 'en bloc' liver/pancreas transplantation ↗

  2012
  not yet assessed
• CD151 Amplifies Signaling by Integrin α6β1 to PI3K and Induces the Epithelial–Mesenchymal Transition in HCC Cells ↗

  Gastroenterology · 2011 · PMID 21320503
  not yet assessed
• Profiling of the Tetraspanin CD151 Web and Conspiracy of CD151/Integrin β1 Complex in the Progression of Hepatocellular Carcinoma ↗

  PLoS ONE · 2011 · PMID 21961047
  not yet assessed
• An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma ↗

  Journal of Cancer Research and Clinical Oncology · 2011 · PMID 21809031
  not yet assessed
• Tacrolimus Enhances the Invasion Potential of Hepatocellular Carcinoma Cells and Promotes Lymphatic Metastasis in a Rat Model of Hepatocellular Carcinoma: Involvement of Vascular Endothelial Growth Factor-C ↗

  Transplantation Proceedings · 2011 · PMID 21911157
  not yet assessed
• Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation ↗

  PLoS ONE · 2011 · PMID 21998744
  not yet assessed
• [Clinical efficacies of ABO-incompatible adult liver transplantation]. ↗

  PubMed · 2011 · PMID 22321886
  not yet assessed
• In Reply to Dr. Hans Christiansen et al. ↗

  International Journal of Radiation Oncology*Biology*Physics · 2011
  not yet assessed
• Title Page / Table of Contents ↗

  Oncology · 2011
  not yet assessed
• CD151 Modulates Expression of Matrix Metalloproteinase 9 and Promotes Neoangiogenesis and Progression of Hepatocellular Carcinoma ↗

  Hepatology · 2010 · PMID 20578262
  not yet assessed
• Up-regulation of Krüppel-Like Factor 8 Promotes Tumor Invasion and Indicates Poor Prognosis for Hepatocellular Carcinoma ↗

  Gastroenterology · 2010 · PMID 20728449
  not yet assessed
• Radiation-Induced Liver Fibrosis Is Mitigated by Gene Therapy Inhibiting Transforming Growth Factor-β Signaling in the Rat ↗

  International Journal of Radiation Oncology*Biology*Physics · 2010 · PMID 20932668
  not yet assessed
• The current status of pediatric liver transplantation in Mainland China ↗

  Pediatric Transplantation · 2010 · PMID 20557474
  not yet assessed
• The diagnosis and treatment of interstitial pneumonia after liver transplantation

  Organ transplantation · 2010
  not yet assessed
• Catheter-related infection in artificial liver support system: a clinical analysis of 698 patients.

  Zhongguo yiyuan ganranxue zazhi · 2010
  not yet assessed
• T helper 17 cells and tumor immunity

  Fudan xuebao. Yixue ban · 2010
  not yet assessed
• Epidemiological effect analysis after inoculation of hepatitis A vaccine

  Chinese Journal of Disease Control and Prevention · 2010
  not yet assessed
• Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma ↗

  Clinical Cancer Research · 2009 · PMID 19188168
  not yet assessed
• Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery ↗

  BMC Cancer · 2009 · PMID 19948069
  not yet assessed
• Treatment for the recurrence of hepatocellular carcinoma following liver transplantation: What is the best strategy? ↗

  Cancer Biology & Therapy · 2009 · PMID 19417558
  not yet assessed
• Spinal fractures complicated with thoracic injuries in 73 cases

  2009
  not yet assessed
• The advances in the study of circulating DNA in early diagnosis and treatment for hepatocellular carcinoma

  Fudan xuebao. Yixue ban · 2009
  not yet assessed
• Use of preoperative serum VEGF and CRP levels for prediction of postoperative early recurrence in patients with hepatocellular carcinoma ↗

  World Chinese Journal of Digestology · 2009
  not yet assessed
• Osteopontin Combined with CD44, a Novel Prognostic Biomarker for Patients with Hepatocellular Carcinoma Undergoing Curative Resection ↗

  The Oncologist · 2008 · PMID 18997126
  not yet assessed
• The DNA-binding Polycomb-group protein Pleiohomeotic maintains both active and repressed transcriptional states through a single site ↗

  Development · 2008 · PMID 19029043
  not yet assessed
• Hepatectomy for liver metastasis of colorectal cancer ↗

  International Journal of Colorectal Disease · 2008 · PMID 19096855
  not yet assessed
• Preventive chemotherapy for hepatocellular carcinoma exceeding Milan criteria after fiver transplantation ↗

  Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi · 2008
  not yet assessed
• [Primary experience of the anatomical laparoscopic left lateral hepatic lobectomy procedure for benign and malignant liver tumors]. ↗

  PubMed · 2008 · PMID 19094754
  not yet assessed
• Effect of PEG-PEI/Fe_3O_4 Nano-magnetic fluid-TK on targeting therapy for implanted liver cancer in nude mice

  Zhongguo xiandai yixue/Zhongguo xiandai yixue zazhi · 2008
  not yet assessed
• Clinical analysis of liver transplantation in the aged patients ↗

  Chineae Journal of Organ Transplantation · 2008
  not yet assessed
• Effects of different methods of liver graft harvesting and perfusion on early liver function after transplantation ↗

  Chineae Journal of Organ Transplantation · 2008
  not yet assessed
• [Pulmonary infection and its risk factors after orthotopic liver transplantation]. ↗

  PubMed · 2007 · PMID 18073066
  not yet assessed
• [Influence of tumor characteristics on the outcome of liver transplantation among patients with hepatocellular carcinoma]. ↗

  PubMed · 2007 · PMID 17988527
  not yet assessed
• Comparison of the complications of treatment of rectal cancer by laparoscopic versus conventional laparotomy procedure

  Medical Information · 2007
  not yet assessed
• [Interferon alpha enhances the sensitivity of SMMC-7721 hepatocellular carcinoma cells to 5'-deoxy-5-fluorouridine related to up-regulation of thymidine phosphorylase]. ↗

  PubMed · 2007 · PMID 17988526
  not yet assessed
• Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience ↗

  World Journal of Gastroenterology · 2006 · PMID 16718799
  not yet assessed
• [The effects of different clinicopathologic variables on serum protein fingerprint in hepatocellular carcinoma patients]. ↗

  PubMed · 2006 · PMID 16772076
  not yet assessed
• [Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience]. ↗

  PubMed · 2006 · PMID 16796877
  not yet assessed
• THEORETICAL ANALYSIS AND CLINICAL OBSERVATION OF “KAIFEIXINGSHUI MEASURES” TREATMENT FOR EXOGENOUS COUGH

  Modern hospital · 2006
  not yet assessed
• [Diagnosis and management for early hepatic artery thrombosis after liver transplantation]. ↗

  PubMed · 2005 · PMID 16251067
  not yet assessed
• [What are the indications of liver transplantion in hepatic cancer patients?]. ↗

  PubMed · 2005 · PMID 16251064
  not yet assessed
• [The effects of portal vein microscopic and macroscopic tumor thrombi on post-operation patients with hepatocellular carcinoma]. ↗

  PubMed · 2005 · PMID 15854367
  not yet assessed
• [Therapeutic effectiveness of liver transplantation: a single center study of 203 consecutive cases]. ↗

  PubMed · 2005 · PMID 16253182
  not yet assessed
• Comparison of serum proteome fingerprint between hepatocellular carcinoma patients with or without metastasis

  Zhonghua shiyan waike zazhi · 2005
  not yet assessed
• Silencing effect of recombinant plasmids PPARgamma-pSUPER-EGFP on the expression of peroxisome proliferator-activated receptor gamma. ↗

  PubMed · 2005 · PMID 16313712
  not yet assessed
• Construction of expression vector for prophylactic myocardial hypertrophy GCIP polypeptide

  Di-san junyi daxue xuebao · 2004
  not yet assessed
• Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor. ↗

  PubMed · 2003 · PMID 14676129
  not yet assessed
• Pseudomonas sp. strain KC represents a new genomovar within Pseudomonas stutzeri. ↗

  INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · 2001 · PMID 11760942
  not yet assessed
• Analysis of antigenic heterogeneity of CagA of Helicobacter pylori strains

  2001
  not yet assessed
• Study on inhibition of the growth and metastasis of LCID20 hepatocellular carcinoma by Capecitabine

  Zhonghua shiyan waike zazhi · 2000
  not yet assessed
• [Construction of a GFP broad-host-range promoter-probe vector and its application]. ↗

  PubMed · 1999 · PMID 12555521
  not yet assessed
• Newsletter – Fall 1998 ↗

  Digestive Surgery · 1998
  not yet assessed
• Acknowledgement to Reviewers ↗

  Digestive Surgery · 1998
  not yet assessed
• Author Index ↗

  Digestive Surgery · 1998
  not yet assessed
• Subject Index ↗

  Digestive Surgery · 1998
  not yet assessed
• [Outward character and inner quality of Bombyx Batryticatus, Carapax Trionycis, Squama Manitis and endothelium corneum Gigeriae Galli after frying]. ↗

  PubMed · 1997 · PMID 11038912
  not yet assessed
• Hepatitis C virus genotype in patients with essential mixed cryoglobulinaemia ↗

  QJM · 1995 · PMID 8542265
  not yet assessed
• ChemInform Abstract: Π‐BIS(BENZENE)CHROMIUM(0)‐CATALYZED OLIGOMERIZATION OF PERFLUOROPROPYLENE ↗

  ChemInform · 1981
  not yet assessed